This must be one of the main announcements of the press conference this Thursday evening.
While France is experiencing a significant epidemic rebound in around ten departments - which has already led to partial re-containments on the coast of the Alpes-Maritimes and in Dunkirk - vaccination remains to this day the favored avenue for ending the crisis.
But that is not the only one.
According to our information, the executive is preparing to invest in monoclonal antibodies, and plans to acquire several tens of millions of euros of drugs.
This technique, which appeared in the early 1980s, was notably used on an experimental basis during Trump's hospitalization in early October.
"Treatments and therapeutic trials"
Emmanuel Macron, who had never heard of it a few months ago, began to take a close interest in the subject this winter.
Just after stumbling across a study by chance, following one of the scientific readings he has become accustomed to.
“He yelled at Olivier Véran a bit,
This article is for subscribers only.
You have 70% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in